Biotech · Private company
Avanir Pharmaceuticals
Track this companyFree. Adds Avanir Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- AVP-923-20Phase 2 · AgitationClinicalTrials.gov · fetched Nov 12, 2026
- AVP-923-20Phase 2 · Central Neuropathic PainClinicalTrials.gov · fetched Nov 12, 2026
- AVP-923-30Phase 2 · AgitationClinicalTrials.gov · fetched Nov 12, 2026
- AVP-923-30Phase 2 · Central Neuropathic PainClinicalTrials.gov · fetched Nov 12, 2026
- AVP-923-45Phase 2 · Central Neuropathic PainClinicalTrials.gov · fetched Nov 12, 2026
- AVP-923-45Phase 2 · DyskinesiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease PatientsPHASE2 · COMPLETED · started Oct 16, 2013ClinicalTrials.gov NCT01767129 · fetched Nov 12, 2026
- Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's DiseasePHASE2 · COMPLETED · started Aug 13, 2012ClinicalTrials.gov NCT01584440 · fetched Nov 12, 2026
- Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple SclerosisPHASE2 · COMPLETED · started Sep 8, 2011ClinicalTrials.gov NCT01324232 · fetched Nov 12, 2026